| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1311297B1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 07/26/2006 | EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP1173550B1 Method for diminishing specific immune reactions |
| 07/26/2006 | EP1072273B1 Vascularization inhibitors |
| 07/26/2006 | EP1027069B1 Gene therapy for gaucher disease |
| 07/26/2006 | EP0985028B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 07/26/2006 | EP0904100B1 Cationic lipid and receptor ligand-facilitated delivery of biologically active molecules |
| 07/26/2006 | EP0856058B1 Cell-cycle checkpoint genes |
| 07/26/2006 | EP0832222B1 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions |
| 07/26/2006 | CN1809633A Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 07/26/2006 | CN1809583A Antisense oligonucleotides that inhibit expression of hif-1 |
| 07/26/2006 | CN1809375A Apoptosis inducing agent and method of inducing apoptosis |
| 07/26/2006 | CN1809374A Proton-sensing G-protein coupled receptors and DNA sequences thereof |
| 07/26/2006 | CN1807648A Recombinant plasmid containing effective B cell activation factor gene promotor and its preparation method and uses |
| 07/26/2006 | CN1807647A Expression plasmid for rep gene, RBE cisform element fixed point integration system and its preparation method and uses |
| 07/26/2006 | CN1807623A Positive regulation gene for cell cycle and its coded protein and uses |
| 07/26/2006 | CN1807621A Exterior guiding gene T7 concurrently used with RnaseP ribozyme and its uses |
| 07/26/2006 | CN1807620A Exterior guiding gene T6 concurrently used with RnaseP ribozyme and its uses |
| 07/26/2006 | CN1807619A Exterior guiding gene C6 concurrently used with RnaseP ribozyme and its uses |
| 07/26/2006 | CN1807617A Expression plasmid for rep gene, P5NIE cisform element fixed point integration system and its preparation method and uses |
| 07/26/2006 | CN1807454A GIBC gene and its coded protein and uses |
| 07/26/2006 | CN1806848A Novel use of thymosin alpha protogene |
| 07/26/2006 | CN1266282C DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 07/26/2006 | CN1266274C Trichosanthin suicide ENH-TCS, recombination vector and application thereof |
| 07/26/2006 | CN1265841C Swing breeding and respiratory syndrome suicide DNA vaccine and use |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081495 Cationic compounds and their use as macro molecular carriers |
| 07/25/2006 | US7081354 Interleukin and albumin fusion protein |
| 07/25/2006 | US7081338 DNA coding for a novel cell adhesion molecule |
| 07/25/2006 | US7081245 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/25/2006 | US7081242 Administering conjugate comprising (a) a non-immunogenic valency platform molecule and (b) two or more molecules comprising double stranded DNA (dsDNA) epitopes, wherein the dsDNA epitopes are polynucleotides which specifically bind to an antibody from the individual |
| 07/20/2006 | WO2006076735A2 Regulating expression of transient receptor potential channel genes |
| 07/20/2006 | WO2006076519A2 Mycobacterial mutants affecting host apoptosis |
| 07/20/2006 | WO2006076408A1 Cancer-targeted viral vectors |
| 07/20/2006 | WO2006076343A1 Mycobacteria expressing hiv-1 and malaria antigens |
| 07/20/2006 | WO2006075819A1 Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 07/20/2006 | WO2006075776A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | WO2006075172A2 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2 |
| 07/20/2006 | WO2006074546A1 Lipid encapsulated interfering rna |
| 07/20/2006 | WO2006051069A3 Defective influenza virus particles |
| 07/20/2006 | WO2006012416A3 Specific inhibition of autoimmunity and diseases associated with autoantigens |
| 07/20/2006 | WO2005108949A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 07/20/2006 | WO2005096693A3 Cancer prognosis and/or diagnosis method |
| 07/20/2006 | WO2003066808A3 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 07/20/2006 | US20060161995 Chimeric mouse in which at least 85% of the human antibody-producing cells retain the human artificial chromosome Delta HAC or Delta Delta HAC. |
| 07/20/2006 | US20060160764 LIMKs as modifiers of p53 pathway and methods of use |
| 07/20/2006 | US20060160763 System for delivering therapeutic agents into living cells and cells nuclei |
| 07/20/2006 | US20060160762 Methods for the treatment, diagnosis, and prognosis of cancer |
| 07/20/2006 | US20060160761 Regulation of vascular endothelium using BMX tyrosine kinase |
| 07/20/2006 | US20060160760 Modulation of glucocorticoid receptor expression |
| 07/20/2006 | US20060160759 Influenza therapeutic |
| 07/20/2006 | US20060160758 Antisense modulation of CD40 ligand expression |
| 07/20/2006 | US20060160757 RNA interference mediated inhibition hairless of (HR) gene expression using short interfering nucleic acid (siNA) |
| 07/20/2006 | US20060160733 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 07/20/2006 | US20060160731 Peptide nucleic acids |
| 07/20/2006 | US20060160154 Materials and methods for detection and treatment of breast cancer |
| 07/20/2006 | US20060160143 Mitogenic oxygenases |
| 07/20/2006 | US20060160132 Diagnositics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 07/20/2006 | US20060160123 For increasing stability of short interfering RNA molecule when in contact with biological sample, and reducing off-target effects/interferon responsiveness; ribonuclease stability |
| 07/20/2006 | US20060160095 Survivin |
| 07/20/2006 | US20060160088 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 40 (gpr40) |
| 07/20/2006 | US20060160076 Methods of treating and diagnosing diabetes with cx3cr1 modulators |
| 07/20/2006 | US20060160073 Efficient algorithm for PCR testing of blood samples |
| 07/20/2006 | US20060160067 GBV-B polynucleotide coding a virus having domain III of the 5' neurotrophin region from a hepatitis C virus 5' NTR, and at least part of a structural or non-structural protein coding region of HCV; viral expression construct; infectious GBV-B molecular clone |
| 07/20/2006 | US20060159769 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 07/20/2006 | US20060159764 for delivery of nucleic acids for example; noncovalently associating molecules with the polyion in a solution outside a cell; adding a crosslinker that contains a disulfide bond and forms covalent linkages between moieties of the molecules in the presence of the polyion, to form a complex |
| 07/20/2006 | US20060159737 Pharmaceutical compositions for local administration |
| 07/20/2006 | US20060159706 Novel insertion sites in pox vectors |
| 07/20/2006 | US20060159681 Compositions and methods to inhibit cell loss by using inhibitors of BAG |
| 07/20/2006 | US20060159670 Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors |
| 07/20/2006 | US20060159669 Novel uses of PPAR modulators and professional APCs manipulated by the same |
| 07/20/2006 | US20060159662 Therapeutic anti-melanoma compounds |
| 07/20/2006 | US20060159659 RNA picornavirus; selectively kills some types of tumors; making new oncolytic virus derivatives and of altering viruses to have tumor-specific tropisms |
| 07/20/2006 | US20060159654 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE |
| 07/20/2006 | US20060159623 Stem cells for use in locating and targeting tumor cells |
| 07/20/2006 | US20060159619 Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids ("PNAs") with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer |
| 07/20/2006 | DE102005003788A1 siRNA-Moleküle zur Behandlung von Blutgefäßen siRNA molecules for the treatment of blood vessels |
| 07/20/2006 | CA2597698A1 Mycobacterial mutants affecting host apoptosis |
| 07/20/2006 | CA2594675A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | CA2593684A1 Cancer-targeted viral vectors |
| 07/20/2006 | CA2567047A1 Alphavirus replicon packaging constructs |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |
| 07/19/2006 | EP1681353A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35 |
| 07/19/2006 | EP1681348A1 MU-1 member of the cytokine receptor family |
| 07/19/2006 | EP1681347A1 Improved methods for double-stranded RNA mediated gene silencing |
| 07/19/2006 | EP1681346A1 Recombinant virus vector originating in hhv-6 or hhv-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same |
| 07/19/2006 | EP1680508A1 Site-specific intestinal delivery and/or production of biologically active substances |
| 07/19/2006 | EP1680446A2 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
| 07/19/2006 | EP1680439A2 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 07/19/2006 | EP1680145A2 Methods and compositions for the treatment of neurological disease |
| 07/19/2006 | EP1680085A1 A novel cationic lipopolymer as a biocompatible gene delivery agent |
| 07/19/2006 | EP1680009A2 Compositions and methods for diagnosing and treating mental disorders |
| 07/19/2006 | EP1546322A4 Transposon-based vectors and methods of nucleic acid integration |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1282712B1 Synthetic gagpol genes and their uses |
| 07/19/2006 | EP1223930B1 Treatment of dyskinesia |
| 07/19/2006 | EP1076566B1 Attenuated mutants of salmonella which constitutively express the vi antigen |